Misplaced Pages

The following pages link to Breakthrough therapy

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• Pembrolizumab (links | edit)
• Moderna (links | edit)
• Pritelivir (links | edit)
• Advanced Accelerator Applications (links | edit)
• Fostemsavir (links | edit)
• Balovaptan (links | edit)
• Chikungunya vaccine (links | edit)
• RVSV-ZEBOV vaccine (links | edit)
• Betibeglogene autotemcel (links | edit)
• List of drugs granted breakthrough therapy designation (links | edit)
• Ombitasvir/paritaprevir/ritonavir (links | edit)
• Enfortumab vedotin (links | edit)
• Polatuzumab vedotin (links | edit)
• Durvalumab (links | edit)
• Evinacumab (links | edit)
• Lumacaftor/ivacaftor (links | edit)
• Sacituzumab govitecan (links | edit)
• Scioderm (links | edit)
• Breakthrough Therapy (redirect page) (links | edit)
  • Drug development (links | edit)
  • Teprotumumab (links | edit)
  • Seth Lederman (links | edit)
  • Rapastinel (links | edit)
  • Palbociclib (links | edit)
  • Scioderm (links | edit)
  • Specialty drugs in the United States (links | edit)
  • Rindopepimut (links | edit)
  • Tonix Pharmaceuticals (links | edit)
  • COVID-19 drug development (links | edit)
• Specialty drugs in the United States (links | edit)
• Osimertinib (links | edit)
• Avelumab (links | edit)
• Breakthrough Therapy Designation (redirect page) (links | edit)
  • Psilocybin mushroom (links | edit)
  • Vocimagene amiretrorepvec/flucytosine (links | edit)
  • Kite Pharma (links | edit)
  • Pevonedistat (links | edit)
• Venetoclax (links | edit)
• Pexidartinib (links | edit)
• Abemaciclib (links | edit)
• Breakthrough therapy (FDA) (redirect page) (links | edit)
  • Talk:Breakthrough therapy (FDA) (transclusion) (links | edit)
  • User:KadaneBot/Task3/R from unnecessary disambiguation (links | edit)
  • User:KadaneBot/Task3/Case 1/2 (links | edit)
  • User:KadaneBot/Task3/Edits/other/Case 1/6 (links | edit)
• Niraparib (links | edit)
• Entrectinib (links | edit)
• Uridine triacetate (links | edit)
• Breakthrough therapy designation (redirect page) (links | edit)
  • Neurofibromin (links | edit)
  • PVSRIPO (links | edit)
  • Reid Robison (links | edit)
  • Emicizumab (links | edit)
  • Patisiran (links | edit)
• Asfotase alfa (links | edit)
• Galcanezumab (links | edit)
• Lanadelumab (links | edit)
• Capmatinib (links | edit)
• Burosumab (links | edit)
• Crizanlizumab (links | edit)
• Olmutinib (links | edit)
• Breakthrough status (redirect page) (links | edit)
  • Novimmune (links | edit)
• Breakthrough drug (redirect page) (links | edit)
  • Volasertib (links | edit)
• Emapalumab (links | edit)
• Larotrectinib (links | edit)
• Tucatinib (links | edit)
• Erdafitinib (links | edit)
• Trilaciclib (links | edit)
• Nemolizumab (links | edit)
• Tisagenlecleucel (links | edit)
• Axicabtagene ciloleucel (links | edit)
• Umbralisib (links | edit)
• Cerliponase alfa (links | edit)